Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies
- PMID: 12614093
- DOI: 10.7326/0003-4819-138-5-200303040-00010
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies
Abstract
Alzheimer disease is a complex neurodegenerative dementing illness. It has become a major public health problem because of its increasing prevalence, long duration, high cost of care, and lack of disease-modifying therapy. Over the past few years, however, remarkable advances have taken place in understanding both the genetic and molecular biology associated with the intracellular processing of amyloid and tau and the changes leading to the pathologic formation of extracellular amyloid plaques and the intraneuronal aggregation of hyperphosphorylated tau into neurofibrillary tangles. The identification of disease-causing autosomal dominant mutations as well as gene polymorphisms that alter the risk for pathology indicate that Alzheimer disease is a genetically complex disorder. This progress in our understanding of the molecular pathology has set the stage for clinically meaningful advances in diagnosis and treatment. Emerging diagnostic methods that are based on biochemical and imaging biomarkers of disease-specific pathology hold the potential for accurately diagnosing Alzheimer disease at the earliest stage of the illness--the time when disease-modifying treatment will be most effective. Currently available cholinesterase inhibition therapy targets the cognitive symptoms. However, the goal of new therapies under development is halting the pathologic cascade and potentially reversing the course of the disease. If these new therapies are successful, they will represent a remarkable medical advance for patients and the families who care for them.
Comment in
-
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.Ann Intern Med. 2004 Jan 6;140(1):71. doi: 10.7326/0003-4819-140-1-200401060-00031. Ann Intern Med. 2004. PMID: 14706987 No abstract available.
Similar articles
-
Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.J Neural Transm (Vienna). 2004 Mar;111(3):247-72. doi: 10.1007/s00702-003-0065-z. Epub 2003 Dec 3. J Neural Transm (Vienna). 2004. PMID: 14991453 Review.
-
[Alzheimer disease: cellular and molecular aspects].Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. Bull Mem Acad R Med Belg. 2005. PMID: 16768248 French.
-
[Therapy of Alzheimer disease].Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Neuropsychopharmacol Hung. 2009. PMID: 19731816 Review. Hungarian.
-
Experimental approaches to cognitive disturbance in Alzheimer's disease.Harv Rev Psychiatry. 1998 May-Jun;6(1):11-22. doi: 10.3109/10673229809010950. Harv Rev Psychiatry. 1998. PMID: 10370429 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Mefenamic Acid Loaded and TPGS Stabilized Mucoadhesive Nanoemulsion for the Treatment of Alzheimer's Disease: Development, Optimization, and Brain-Targeted Delivery via Olfactory Pathway.AAPS PharmSciTech. 2024 Jan 10;25(1):16. doi: 10.1208/s12249-023-02727-0. AAPS PharmSciTech. 2024. PMID: 38200387
-
Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.J Am Soc Mass Spectrom. 2010 Sep;21(9):1506-14. doi: 10.1016/j.jasms.2010.05.007. Epub 2010 May 31. J Am Soc Mass Spectrom. 2010. PMID: 20580569
-
Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study.Alzheimers Res Ther. 2021 Apr 21;13(1):87. doi: 10.1186/s13195-021-00816-5. Alzheimers Res Ther. 2021. PMID: 33883008 Free PMC article. Clinical Trial.
-
Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.Front Cell Neurosci. 2018 Aug 21;12:258. doi: 10.3389/fncel.2018.00258. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30186116 Free PMC article. Review.
-
Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer's Disease.Brain Sci. 2023 Jan 27;13(2):213. doi: 10.3390/brainsci13020213. Brain Sci. 2023. PMID: 36831756 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous